JNJ

Johnson & Johnson
D

JNJ

156.120
USD
1.72
(1.11%)
Market Closed
Volume
260,996
EPS
11
Div Yield
3.21
P/E
17
Market Cap
375,636,160,317
Signals
هشام منسي
هشام منسي
1 month ago
sell
JNJ
JNJ@161.03
2025-03-26 04:10
JNJ@161.03 Chart
Profit
-149.00
sara abdelazim
sara abdelazim
1 year ago
sell
JNJ
JNJ@172.81
2023-08-18 10:04
JNJ@172.81 Chart
Profit
13.00
More
Related Instruments
ABT
ABT
1.930
(1.47%)
132.820 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
BMY
BMY
1.000
(2.02%)
50.560 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
GSK
GSK
-0.120
(-0.31%)
39.070 USD
LLY
LLY
10.33
(1.27%)
823.96 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
SYK
SYK
4.11
(1.10%)
378.26 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
More
News

Title: Johnson & Johnson

Sector: Healthcare
Industry: Drug Manufacturers - General
Johnson & Johnson is an American multinational corporation founded in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. The company’s ethos is centered around good health as the foundation of vibrant lives. Since its inception, it has continued this mission and is now considered the world’s largest and most broadly based healthcare company, with more than 140,000 employees around the world. The company develops medical devices, pharmaceuticals, and consumer packaged goods. It features prominently in the top 50 of the Fortune 500 list of corporations by total revenue. The company is headquartered in New Brunswick, New Jersey. Its holdings include some 250 subsidiary companies with operations in 60 countries and products sold in over 175 nations. Among its best-known brand assets are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin products, and more.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.